Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
NCT06638749Phase 3Withdrawn
- Sponsor
- University of Kansas Medical Center
- Start
- May 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in shoulder arthritis, sponsored by University of Kansas Medical Center. Primary endpoint: Intra-operative blood loss. Planned start May 2019; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
shoulder arthritis
Beyond the preview
Go deeper on NCT06638749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06638749.